![]() | Up a level |
2017
Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Leguay, Thibaut, Maertens, Johan
ORCID: 0000-0003-4257-5980, Vehreschild, Maria J. G. T.
ORCID: 0000-0003-0446-3224, Anagnostopoulos, Achilles
ORCID: 0000-0003-4384-9031, Castagnola, Carlo, Verga, Luisa, Rieger, Christina, Kondakci, Mustafa, Harter, Georg
ORCID: 0000-0001-9946-6246, Duarte, Rafael F., Allione, Bernardino, Cordonnier, Catherine, Heussel, Claus Peter
ORCID: 0000-0001-5809-5733, Morrissey, C. Orla
ORCID: 0000-0002-9970-9575, Agrawal, Samir G., Donnelly, J. Peter
ORCID: 0000-0002-8521-335X, Bresnik, Mark, Hawkins, Michael J., Garner, Will
ORCID: 0000-0003-0738-8696, Goekbuget, Nicola and Fätkenheuer, Gerd
ORCID: 0000-0002-5054-1871
(2017).
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
J. Antimicrob. Chemother., 72 (8).
S. 2359 - 2368.
OXFORD UNIV PRESS.
ISSN 1460-2091
2014
Cornely, Oliver, Leguay, Thibaut, Maertens, Johan, Castagnola, Carlo, Anagnostopoulos, Achilles, Allione, Bernadino, Heussel, Claus Peter, Donnelly, J. Peter, Agrawal, Samir G., Garner, Will, Simcock, Catherine, Hawkins, Michael J. and Goekbuget, Nicola (2014). A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome (R)) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020